We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$2.21B
AUM Growth
+$402M
(+22%)
Cap. Flow
+$267M
Cap. Flow
% of AUM
12.07%
Top 10 Holdings %
Top 10 Hldgs %
16.09%
Holding
1,247
New
172
Increased
894
Reduced
64
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.97M |
| 2 |
Apple
AAPL
|
+$8.92M |
| 3 |
Amazon
AMZN
|
+$8.89M |
| 4 |
Broadcom
AVGO
|
+$8.06M |
| 5 |
BF
BASF AKTIENGESELLT ADS(RP1 ORD
BF
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$3.45M |
| 2 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$3.39M |
| 3 |
MSCI
MSCI
|
+$3.27M |
| 4 |
Broadridge
BR
|
+$3.02M |
| 5 |
MON
Monsanto Co
MON
|
+$2.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 12.6% |
| 3 | Healthcare | 11.99% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Tyler Technologies
TYL
$12.2B
| $2.5M | 0.11% |
11,261
+1,508
| +15% | +$339K |
|
177
Stryker
SYK
$127B
| $2.5M | 0.11% |
14,795
+2,480
| +20% | +$417K |
|
178
Chemours
CC
$2.59B
| $2.5M | 0.11% |
56,279
+5,035
| +10% | +$250K |
|
179
BCE
BCE
$19.9B
| $2.49M | 0.11% |
+61,495
| New | +$2.58M |
|
180
Teradyne
TER
$54.8B
| $2.47M | 0.11% |
64,913
+10,830
| +20% | +$422K |
|
181
RPM International
RPM
$13.7B
| $2.47M | 0.11% |
42,304
+5,313
| +14% | +$266K |
|
182
Northrop Grumman
NOC
$77B
| $2.47M | 0.11% |
8,014
+1,364
| +21% | +$451K |
|
183
Regeneron Pharmaceuticals
REGN
$68.8B
| $2.43M | 0.11% |
7,035
+1,258
| +22% | +$393K |
|
|
FISV
184
Fiserv Inc
FISV
$27.2B
| $2.43M | 0.11% |
32,738
+4,654
| +17% | +$338K |
|
185
Zebra Technologies
ZBRA
$12.4B
| $2.42M | 0.11% |
16,894
+2,159
| +15% | +$318K |
|
186
WEX
WEX
$6.11B
| $2.41M | 0.11% |
12,671
+1,804
| +17% | +$315K |
|
187
S&P Global
SPGI
$126B
| $2.41M | 0.11% |
11,819
+978
| +9% | +$193K |
|
188
Cognex
CGNX
$10.3B
| $2.4M | 0.11% |
53,773
+5,746
| +12% | +$272K |
|
189
General Motors
GM
$74.7B
| $2.4M | 0.11% |
60,838
+11,566
| +23% | +$455K |
|
190
Factset
FDS
$9.05B
| $2.4M | 0.11% |
12,096
+1,295
| +12% | +$259K |
|
191
Jones Lang LaSalle
JLL
$15.1B
| $2.39M | 0.11% |
14,387
+2,031
| +16% | +$345K |
|
192
Graco
GGG
$12.9B
| $2.37M | 0.11% |
52,509
+5,616
| +12% | +$258K |
|
193
General Dynamics
GD
$105B
| $2.37M | 0.11% |
12,728
+2,108
| +20% | +$432K |
|
|
ULTI
194
DELISTED
Ultimate Software Group Inc
ULTI
| $2.37M | 0.11% |
9,197
+1,158
| +14% | +$297K |
|
195
Kilroy Realty
KRC
$4.58B
| $2.37M | 0.11% |
31,266
+3,945
| +14% | +$289K |
|
196
Ventas
VTR
$48.9B
| $2.36M | 0.11% |
41,401
-1,234
| -3% | -$64.6K |
|
197
American Financial Group
AFG
$11.9B
| $2.35M | 0.11% |
21,942
+2,856
| +15% | +$316K |
|
198
MarketAxess Holdings
MKTX
$4.15B
| $2.35M | 0.11% |
11,894
+1,626
| +16% | +$337K |
|
199
Lennox International
LII
$18.8B
| $2.33M | 0.11% |
11,647
+1,245
| +12% | +$252K |
|
200
West Pharmaceutical
WST
$23.1B
| $2.31M | 0.1% |
23,275
+3,187
| +16% | +$293K |
|
Similar funds
SAM
Pacer Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Pacer Advisors held 1,247 positions worth $2.21B, up 22% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Pacer Advisors deployed $267M of net new capital in Q2 2018, opening 172 new positions and adding to 894 existing holdings. Its largest new stake was Broadcom: 328,700 shares worth $7.98M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Abiomed Inc, an estimated $3.45M trimmed.
- Pacer Advisors's largest Q2 2018 buy was Broadcom: 328,700 shares worth $7.98M.
- Pacer Advisors added most to Microsoft in Q2 2018, an estimated $8.97M increase.
- Pacer Advisors's biggest Q2 2018 reduction was Abiomed Inc, cutting an estimated $3.45M.
- Pacer Advisors fully exited Royal Dutch Shell PLC ADS Class B in Q2 2018, selling an estimated $3.39M.
- Pacer Advisors's ten largest holdings make up 16% of its $2.21B portfolio in Q2 2018.
- Pacer Advisors opened 172 new positions and closed 79 in Q2 2018.
- Pacer Advisors's portfolio value rose 22% quarter-over-quarter to $2.21B.
Based on Pacer Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.